Search results for "Infectious Diseases"
New Bedside Rounds podcast: Bacteriophages making a comeback
Discover how bacteriophages were once used to treat all kinds of infections, from cholera to staph.
https://immattersacp.org/weekly/archives/2018/12/11/5.htm
11 Dec 2018
Research, regulators consider booster dose of COVID-19 vaccine
FDA advisors recommended boosters for older and high-risk patients. The latest COVID-19 research looked at vaccine effectiveness, remdesivir's effects, an early indicator of vaccine-induced immune thrombotic thrombocytopenia, and rates of follow-up after hospitalization.
https://immattersacp.org/weekly/archives/2021/09/21/1.htm
21 Sep 2021
Studies find monoclonal antibodies and remdesivir effective, while vaccine-associated myocarditis is rare
A trial of casirivimab plus imdevimab indicated it reduced risk of hospitalization or death, the CDC urged vaccination during pregnancy and updated its v-safe tool, and an analysis showed that postvaccine myocarditis occurred in men and resolved with conservative treatment.
https://immattersacp.org/weekly/archives/2021/10/05/1.htm
5 Oct 2021
New info, resources on novel coronavirus disease (COVID-19)
ACP is offering an updated online learning activity and a podcast to help physicians learn about coronavirus. CME credit is free for members upon completion of either activity.
https://immattersacp.org/weekly/archives/2020/03/03/1.htm
3 Mar 2020
Boosters, convalescent plasma, long-term effects, and other COVID-19 news
Government officials announced that they plan to offer booster shots for the mRNA COVID-19 vaccines. Convalescent plasma didn't improve outcomes for high-risk outpatients in a trial, and two studies reported long-term effects of hospitalization for COVID-19.
https://immattersacp.org/weekly/archives/2021/08/24/1.htm
24 Aug 2021
Comprehensive study finds vaccines remarkably safe
The most common safety issue that resulted in label changes for vaccines was a restriction on the population to be vaccinated, such as pregnant or immunocompromised patients.
https://immattersacp.org/weekly/archives/2020/07/28/4.htm
28 Jul 2020
Working together to stop superbugs
The battle against antimicrobial resistance requires a broad line of attack, prompting the CDC to fund projects to expand regional efforts against multidrug-resistant organisms.
https://immattersacp.org/archives/2020/02/working-together-to-stop-superbugs.htm
1 Feb 2020
Latest COVID-19 research looks at obesity, AKI, nursing home prescribing, symptom checkers
Acute kidney injury (AKI) may have more severe consequences after COVID-19, nursing home residents received risky drugs during the pandemic, and an online symptom checker didn't triage safely, but preprocedural COVID-19 testing showed that vaccinations reduced asymptomatic infections.
https://immattersacp.org/weekly/archives/2021/03/16/1.htm
16 Mar 2021
Recent research looks at remdesivir, steroids, biomarkers for COVID-19
Trials have found some potential benefit from remdesivir, early treatment with methylprednisolone, and measurement of C-reactive protein. Early vaccine trial results and guidance on antibody testing were also recently released.
https://immattersacp.org/weekly/archives/2020/06/02/1.htm
2 Jun 2020
CDC releases interim monkeypox guidance, reports epidemiologic and clinical characteristics
The interim guidance focused on prevention and treatment of monkeypox in persons with HIV infection. The most frequently reported signs and symptoms from recent cases of monkeypox in the U.S. include rash (100%), fever (63%), chills (59%), and lymphadenopathy (59%).
https://immattersacp.org/weekly/archives/2022/08/16/1.htm
16 Aug 2022